Franklin Resources’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.06M | Sell |
37,430
-29,465
| -44% | -$837K | ﹤0.01% | 1958 |
|
2025
Q1 | $1.97M | Buy |
66,895
+3,496
| +6% | +$103K | ﹤0.01% | 1687 |
|
2024
Q4 | $1.84M | Sell |
63,399
-9,648
| -13% | -$281K | ﹤0.01% | 1754 |
|
2024
Q3 | $3.41M | Buy |
73,047
+50,908
| +230% | +$2.38M | ﹤0.01% | 1518 |
|
2024
Q2 | $904K | Buy |
+22,139
| New | +$904K | ﹤0.01% | 1962 |
|
2023
Q4 | – | Sell |
-344,328
| Closed | -$2.2M | – | 2695 |
|
2023
Q3 | $2.2M | Buy |
344,328
+114
| +0% | +$727 | ﹤0.01% | 1358 |
|
2023
Q2 | $3.82M | Sell |
344,214
-185,515
| -35% | -$2.06M | ﹤0.01% | 1189 |
|
2023
Q1 | $8.13M | Buy |
529,729
+179,666
| +51% | +$2.76M | ﹤0.01% | 975 |
|
2022
Q4 | $7.77M | Buy |
+350,063
| New | +$7.77M | ﹤0.01% | 1008 |
|
2020
Q3 | – | Sell |
-300,000
| Closed | -$7.11M | – | 1888 |
|
2020
Q2 | $7.11M | Buy |
+300,000
| New | +$7.11M | ﹤0.01% | 937 |
|